FDA Approves New Pancreatic Cancer Treatment

Why it matters locally: The FDA's approval of a new pancreatic cancer treatment offers a new option for Ohio patients battling the disease, potentially impacting treatment protocols at medical facilities across the state.

U.S. health officials approved a new drug for pancreatic cancer. The Food and Drug Administration (FDA) announced the approval, which introduces a different method for treating the illness. The drug functions by blocking a protein that contributes to tumor growth. This protein is present in most pancreatic cancer cases. The new treatment targets this specific mechanism.